CMS, Russia is pleased to announce the appointment of Vsevolod Tyupa as Head of the Lifesciences group in Moscow. Vsevolod has vast experience in advising clients in the pharmaceutical sector on legal regulation relating to the circulation of medicines, clinical trials, different civil and corporate law issues, antitrust matters and dispute resolutions.
Vsevolod will lead one of the top Lifesciences groups in Russia, which is part of CMS’ global Lifesciences group of more than 250 experts across Europe. For the last two years, CMS has been the number one law firm in Europe for the number of M&A deals in the sector. Prior to joining CMS, Vsevolod worked for Roche – one of the world’s leading pharmaceutical companies.
Jean-Francois Marquaire, Managing partner of CMS, Russia comments, “We are delighted to welcome Vsevolod in his new position as Head of Lifesciences in Russia. He will continue developing this strategically important sector for us and providing clients with comprehensive legal advice on their industry-focused projects”.